Efficacy and Safety of Dofetilide in the Treatment of Frequent Ventricular Tachyarrhythmias After Amiodarone Intolerance or FailurePINTER, Arnold; AKHTARI, Shadi; O'CONNELL, Timothy et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 3, pp 380-381, issn 0735-1097, 2 p.Article

Practitioner acceptance of the dofetilide risk-management programLAPOINTE, Nancy M; KRAMER, Judith M; WEINFURT, Kevin P et al.Pharmacotherapy. 2002, Vol 22, Num 8, pp 1041-1046, issn 0277-0008Article

Coronary Artery Disease Potentiates Response to Dofetilide for Rhythm Control of Atrial FibrillationMANOCHA, Pankaj; BAVIKATI, Venkata; LANGBERG, Jonathan et al.Pacing and clinical electrophysiology. 2012, Vol 35, Num 2, pp 170-173, issn 0147-8389, 4 p.Article

Dofetilide Promotes Repolarization Abnormalities in Perfused Guinea-pig HeartOSADCHII, Oleg E.Cardiovascular drugs and therapy. 2012, Vol 26, Num 6, pp 489-500, issn 0920-3206, 12 p.Article

Effect of Dofetilide on the pharmacokinetics of DigoxinKLEINERMANS, Diane; NICHOLS, Donald J; DALRYMPLE, Isobel et al.The American journal of cardiology. 2001, Vol 87, Num 2, pp 248-250, issn 0002-9149Article

Comparison of kinetic properties of quinidine and dofetilide block of HERG channelsTSUJIMAE, Kenji; SUZUKI, Shingo; YAMADA, Mitsuhiko et al.European journal of pharmacology. 2004, Vol 493, Num 1-3, pp 29-40, issn 0014-2999, 12 p.Article

Evaluation of the dofetilide risk-management programLAPOINTE, Nancy M; CHEN, Anita; HAMMILL, Bradley et al.The American heart journal. 2003, Vol 146, Num 5, pp 894-901, issn 0002-8703, 8 p.Article

Molecular physiology and pharmacology of HERG : Single-channel currents and block by dofetilideKIEHN, J; LACERDA, A. E; WIBLE, B et al.Circulation (New York, N.Y.). 1996, Vol 94, Num 10, pp 2572-2579, issn 0009-7322Article

Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium currentLIU, Qiang-Ni; LI ZHANG; GONG, Pei-Li et al.Canadian journal of physiology and pharmacology. 2009, Vol 87, Num 11, pp 954-962, issn 0008-4212, 9 p.Article

Allosteric modulators of the hERG K⁺ channel Radioligand binding assays reveal allosteric characteristics of dofetilide analogsZHIYI YU; KLAASSE, Elisabeth; HEITMAN, Laura H et al.Toxicology and applied pharmacology. 2014, Vol 274, Num 1, pp 78-86, issn 0041-008X, 9 p.Article

Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators : a systematic reviewFERREIRA-GONZALEZ, Ignacio; DOS-SUBIRA, Laura; GUYATT, Gordon H et al.European heart journal. 2007, Vol 28, Num 4, pp 469-477, issn 0195-668X, 9 p.Article

Blockade of I_Ks by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventriclesSO, Petsy Pui-Sze; HU, Xu-Dong; BACKX, Peter H et al.British journal of pharmacology. 2006, Vol 148, Num 3, pp 255-263, issn 0007-1188, 9 p.Article

Effects of Intravenous Dofetilide in patients with frequent premature ventricular contractions: A clinical trialPOOL, P. E; SINGH, S. N; FRIEDRICH, T et al.Clinical cardiology (Mahwah, NJ). 2000, Vol 23, Num 6, pp 415-416, issn 0160-9289Article

Dofetilide Overdose―A Case of Unintentional Ingestion Due to Misinterpretation of the DoseIYER, Praneet S; NEUFELD, Robert J; GIAMBRA, Theresa et al.The Journal of pharmacy technology. 2012, Vol 28, Num 6, pp 258-263, issn 8755-1225, 6 p.Article

Effect of dofetilide on survival in patients with supraventricular arrhythmiasPRITCHETT, E. L. C; WILKINSON, W. E.The American heart journal. 1999, Vol 138, Num 5, pp 994-997, issn 0002-8703, 1Conference Paper

Dynamic analysis of dofetilide-induced changes in ventricular repolarizationLANDE, G; MAISON-BLANCHE, P; FAYN, J et al.Clinical pharmacology and therapeutics. 1998, Vol 64, Num 3, pp 312-321, issn 0009-9236Article

Changes in atrioventricular conduction properties with refractory-period modulationHEWETT, K. W; LE, F. K; MARTIN, K. L et al.Journal of cardiovascular pharmacology. 1996, Vol 28, Num 6, pp 824-832, issn 0160-2446Article

Dofetilide : A class III-specific antiarrhythmic agentKALUS, J. S; MAURO, V. F.The Annals of pharmacotherapy. 2000, Vol 34, Num 1, pp 44-56, issn 1060-0280Article

Rate- and site-dependent effects of propafenone, dofetilide, and the new I_Ks-Blocking agent chromanol 293b on individual muscle layers of the intact canine heartBAUER, A; BECKER, R; KRAFT, P et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 21, pp 2184-2190, issn 0009-7322Article

Molecular determinants of dofetilide block of HERG K⁺ channelsFICKER, E; JAROLIMEK, W; KIEHN, J et al.Circulation research. 1998, Vol 82, Num 3, pp 386-395, issn 0009-7330Article

KCB-328: A novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardiumKIHO LEE; JU YEONG LEE; HAK YEOP KIM et al.Journal of cardiovascular pharmacology. 1998, Vol 31, Num 4, pp 609-617, issn 0160-2446Article

Reduction in fluid secretion by rat testis by drugs that block potassium channelsSETCHELL, B. P; PLÖEN, L; RITZEN, E. M et al.Journal of reproduction and fertility. 1998, Vol 112, Num 1, pp 87-94, issn 0022-4251Article

Combined pharmacological block of I_Kr and I_Ks increases short-term QT interval variability and provokes torsades de pointes. CommentaryTHOMSEN, M. B; LENGYEL, C; VARRO, A et al.British journal of pharmacology. 2007, Vol 151, Num 7, issn 0007-1188, 909-911, 941-951 [14 p.]Article

Class III effects of dofetilide and arrhythmias are modulated by [K⁺]_o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardiumDUCROQ, Joffrey; ROUET, René; SALLE, Laurent et al.European journal of pharmacology. 2006, Vol 532, Num 3, pp 279-289, issn 0014-2999, 11 p.Article

Effects of the Antiarrhythmic Drug Dofetilide on Transmural Dispersion of Repolarization in Ventriculum. A Computer Modeling StudySAIZ, Javier; GOMIS-TENA, Julio; MONSERRAT, Marta et al.IEEE transactions on biomedical engineering. 2011, Vol 58, Num 1, pp 43-53, issn 0018-9294, 11 p.Article